Ganoderma lucidum Polysaccharides Induce Macrophage-Like Differentiation in Human Leukemia THP-1 Cells via Caspase and p53 Activation.
Differentiation therapy by induction of tumor cells is an important method in the treatment of hematological cancers such as leukemia. Tumor cell differentiation ends cancer cells' immortality, thus stopping cell growth and proliferation. In our previous study, we found that fucose-containing polysaccharide fraction F3 extracted from Ganoderma lucidum can bring about cytokine secretion and cell death in human leukemia THP-1 cells. This prompted us to further investigate on how F3 induces the differentiation in human leukemia cells. We integrated time-course microarray analysis and network modeling to study the F3-induced effects on THP-1 cells. In addition, we determined the differentiation effect using Liu's staining, nitroblue tetrazolium (NBT) reduction assay, flow cytometer, western blotting and Q-PCR. We also examined the modulation and regulation by F3 during the differentiation process. Dynamic gene expression profiles showed that cell differentiation was induced in F3-treated THP-1 cells. Furthermore, F3-treated THP-1 cells exhibited enhanced macrophage differentiation, as demonstrated by changes in cell adherence, cell cycle arrest, NBT reduction and expression of differentiation markers including CD11b, CD14, CD68, matrix metalloproteinase-9 and myeloperoxidase. In addition, caspase cleavage and p53 activation were found to be significantly enhanced in F3-treated THP-1 cells. We unraveled the role of caspases and p53 in F3-induced THP-1 cells differentiation into macrophages. Our results provide a molecular explanation for the differentiation effect of F3 on human leukemia THP-1 cells and offer a prospect for a potential leukemia differentiation therapy.
Hsu
Jia-Wei
JW
Institute of Molecular and Cellular Biology, Department of Life Science, Graduate Institute of Biomedical Electronics and Bioinformatics, Center for Systems Biology and Bioinformatics, Institute of Biochemical Sciences, National Taiwan University, Taiwan.
Huang
Hsuan-Cheng
HC
Chen
Shui-Tein
ST
Wong
Chi-Huey
CH
Juan
Hsueh-Fen
HF
Cytokine Growth Factor Rev. 2000 Dec;11(4):303-20
10959078
Cancer Biol Ther. 2002 Nov-Dec;1(6):614-20
12642682
J Immunol. 2004 Nov 15;173(10):5989-99
15528333
Leukemia. 1998 Dec;12(12):1944-50
9844924
Clin Exp Immunol. 1990 Mar;79(3):448-53
2317949
Biotechnol Annu Rev. 2007;13:265-301
17875480
J Biol Chem. 2006 Aug 25;281(34):24111-23
16798741
J Biol Chem. 2003 Dec 19;278(51):51340-6
14534304
Gen Pharmacol. 1999 Jan;32(1):143-54
9888267
BMC Genomics. 2007 Nov 09;8:411
17996095
N Engl J Med. 1999 Sep 30;341(14):1051-62
10502596
Phytochemistry. 2006 Sep;67(18):1985-2001
16905165
Pharmacol Ther. 1997 Oct-Dec;76(1-3):141-9
9535176
Oncogene. 2000 May 15;19(21):2548-56
10851053
Bioorg Med Chem. 2004 Nov 1;12(21):5595-601
15465337
Philos Trans R Soc Lond B Biol Sci. 2007 Jun 29;362(1482):959-71
17317642
Leukemia. 2002 Jun;16(6):1143-53
12040446
Leuk Lymphoma. 2003 Oct;44(10):1641-50
14692514
Cell Death Differ. 2007 Jan;14(1):44-55
17053807
Nat Rev Cancer. 2003 Feb;3(2):89-101
12563308
Blood. 2002 Oct 1;100(7):2421-9
12239152
Nat Rev Cancer. 2007 Mar;7(3):165-8
17332760
Leukemia. 2006 Jun;20(6):941-51
16617325
Curr Drug Targets. 2007 Jun;8(6):685-701
17584025
Nutr Cancer. 2005;53(1):11-7
16351502
J Leukoc Biol. 2007 Sep;82(3):710-20
17595377
Leukemia. 2008 Aug;22(8):1624-7
18305561
Stem Cell Rev. 2005;1(3):197-205
17142856
Blood. 2002 Dec 15;100(13):4446-53
12393560
Cell Death Differ. 2004 Apr;11(4):458-67
14713961
Leuk Res. 1999 Mar;23(3):235-7
10071074
J Leukoc Biol. 2007 Jun;81(6):1568-76
17369494
Cell Signal. 2004 Mar;16(3):365-74
14687666